# ArTara Therapeutics, Inc. — Form D

ArTara Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-09. $4.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-01-09
- Form: D
- Accession: 0001724697-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $4.2M
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2017-12-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302770

## Issuer

- Name: ArTara Therapeutics, Inc.
- CIK: 0001724697
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 302A WEST 12TH STREET, SUITE 254, NEW YORK, NY, 10014
- Phone: 917-744-9933

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Randall Marshall | Director | Newton, MA |
| Jesse Shefferman | Director | New York, NY |
| Randall Marshall | Executive Officer | Newton, MA |
| Jesse Shefferman | Executive Officer | New York, NY |
| David Smith | Executive Officer | Saint Louis, MO |

## More

- [CIK 1724697 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1724697&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001724697-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.